Condoliase

Condoliase (Hernicore) is a biopharmaceutical for the treatment of lumbar disc herniation. It is an enzyme that degrades glycosaminoglycans. Condoliase is derived from the enzyme from the bacteria Proteus vulgaris. It was approved for use in Japan in 2018.

This article is a stub. You can help WikiMD by registering to expand it. Editing is available only to registered and verified users. WikiMD is a comprehensive, free health & wellness encyclopedia.